ESIKA description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

ESIKA

Ventura Corporation (San Juan, P.R)

ēsika Hydrated Face Makeup Foundation SPF 15


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

Drug Facts

Active Ingredients

Octinoxate (6%)

Purpose

Sunscreen

ESIKA Uses

  • helps prevent sunburn.
  • higher SPF gives more sunburn protection.
  • provides moderate protection against sunburn.

Warnings

  • For external use only.

When using this product

  • keep out of eyes. Rinse with water to remove.

Stop use and ask a doctor if

  • rash and irritation develops and lasts.
  • Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

  • apply smoothly every morning before sun exposure and as needed.
  • apply to the forehead, nose, chin and both cheeks. Blend with circular motion and spread softly.
  • moderate sun protection product.

ESIKA Other information

  • Sun alert: Limiting sun exposure, wearing protective clothing, and using sunscreens may reduce the risk of skin aging, skin cancer, and other harmful effects of the sun.

Inactive ingredients

Aqua (water), coco-caprylate/caprate, ethylhexyl palmitate, glycerin, octyldodecanol, polymethyl methacrylate, cyclopentasiloxane, cetyl peg/ppg-10/1 dimethicone, polyglyceryl-4 isostearate, sodium chloride, talc, dimethicone, hexyl laurate, dimethicone/vinyl dimethicone crosspolymer, cyclomethicone, disteardimonium hectorite, cyclohexasiloxane, glycine soja protein (glycine soja (soybean) protein), microcrystalline wax, diazolidinyl urea, cetearyl dimethicone crosspolymer, methylparaben, propylparaben, tocopheryl acetate, petrolatum, dimethiconol, phospholipids, cholesterol, silica, bha, bht, candelilla cera (euphorbia cerifera (candelilla) wax), beeswax, cetearyl alcohol, cetearyl glucoside, copernicia cerifera cera (copernicia cerifera (carnauba) wax), polyglyceryl-2 dipolyhydroxystearate, glycosphingolipids, triethoxycaprylylsilane, ci 77891 (titanium dioxide ), ci 77492 (iron oxides), ci 77491( iron oxides), ci 77499 (iron oxides).

PRINCIPAL DISPLAY PANEL - 30 g Carton

ēsika

Hydrated Face Makeup Foundation SPF 15

30 g e (1 oz.)

ESIKA

ESIKA

OCTINOXATE POWDER

Product Information

Product Type Human otc drug label Item Code (Source) NDC:13537-317
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 0.06 g

Inactive Ingredients

Ingredient Name Strength
water
ETHYLHEXYL PALMITATE
GLYCERIN
OCTYLDODECANOL
CYCLOMETHICONE 5
POLYGLYCERYL-4 ISOSTEARATE
SODIUM CHLORIDE
talc
DIMETHICONE
HEXYL LAURATE
cyclomethicone
CYCLOMETHICONE 6
SOYBEAN
MICROCRYSTALLINE WAX
DIAZOLIDINYL UREA
METHYLPARABEN
PROPYLPARABEN
petrolatum
TRIETHOXYCAPRYLYLSILANE
CHOLESTEROL
SILICON DIOXIDE
BUTYLATED HYDROXYANISOLE
BUTYLATED HYDROXYTOLUENE
CANDELILLA WAX
YELLOW WAX
CETOSTEARYL ALCOHOL
CETEARYL GLUCOSIDE
carnauba wax
titanium dioxide
FERRIC OXIDE YELLOW
ferric oxide red
FERROSOFERRIC OXIDE

Product Characteristics

Color
BROWN (Beige 1)

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:13537-317-01 30 in 1 JAR
2 NDC:13537-317-02 1 in 1 BOX

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2011-05-17


ESIKA

OCTINOXATE POWDER

Product Information

Product Type Human otc drug label Item Code (Source) NDC:13537-318
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 0.06 g

Inactive Ingredients

Ingredient Name Strength
water
ETHYLHEXYL PALMITATE
GLYCERIN
OCTYLDODECANOL
CYCLOMETHICONE 5
POLYGLYCERYL-4 ISOSTEARATE
SODIUM CHLORIDE
talc
DIMETHICONE
HEXYL LAURATE
cyclomethicone
CYCLOMETHICONE 6
SOYBEAN
MICROCRYSTALLINE WAX
DIAZOLIDINYL UREA
METHYLPARABEN
PROPYLPARABEN
petrolatum
TRIETHOXYCAPRYLYLSILANE
CHOLESTEROL
SILICON DIOXIDE
BUTYLATED HYDROXYANISOLE
BUTYLATED HYDROXYTOLUENE
CANDELILLA WAX
YELLOW WAX
CETOSTEARYL ALCOHOL
CETEARYL GLUCOSIDE
carnauba wax
titanium dioxide
FERRIC OXIDE YELLOW
ferric oxide red
FERROSOFERRIC OXIDE

Product Characteristics

Color
BROWN (Beige 2)

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:13537-318-01 30 in 1 JAR
2 NDC:13537-318-02 1 in 1 BOX

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2011-05-17


ESIKA

OCTINOXATE POWDER

Product Information

Product Type Human otc drug label Item Code (Source) NDC:13537-319
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 0.06 g

Inactive Ingredients

Ingredient Name Strength
water
ETHYLHEXYL PALMITATE
GLYCERIN
OCTYLDODECANOL
CYCLOMETHICONE 5
POLYGLYCERYL-4 ISOSTEARATE
SODIUM CHLORIDE
talc
DIMETHICONE
HEXYL LAURATE
cyclomethicone
CYCLOMETHICONE 6
SOYBEAN
MICROCRYSTALLINE WAX
DIAZOLIDINYL UREA
METHYLPARABEN
PROPYLPARABEN
petrolatum
TRIETHOXYCAPRYLYLSILANE
CHOLESTEROL
SILICON DIOXIDE
BUTYLATED HYDROXYANISOLE
BUTYLATED HYDROXYTOLUENE
CANDELILLA WAX
YELLOW WAX
CETOSTEARYL ALCOHOL
CETEARYL GLUCOSIDE
carnauba wax
titanium dioxide
FERRIC OXIDE YELLOW
ferric oxide red
FERROSOFERRIC OXIDE

Product Characteristics

Color
BROWN (Beige 3)

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:13537-319-01 30 in 1 JAR
2 NDC:13537-319-02 1 in 1 BOX

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2011-05-17


ESIKA

OCTINOXATE POWDER

Product Information

Product Type Human otc drug label Item Code (Source) NDC:13537-320
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 0.06 g

Inactive Ingredients

Ingredient Name Strength
water
ETHYLHEXYL PALMITATE
GLYCERIN
OCTYLDODECANOL
CYCLOMETHICONE 5
POLYGLYCERYL-4 ISOSTEARATE
SODIUM CHLORIDE
talc
DIMETHICONE
HEXYL LAURATE
cyclomethicone
CYCLOMETHICONE 6
SOYBEAN
MICROCRYSTALLINE WAX
DIAZOLIDINYL UREA
METHYLPARABEN
PROPYLPARABEN
petrolatum
TRIETHOXYCAPRYLYLSILANE
CHOLESTEROL
SILICON DIOXIDE
BUTYLATED HYDROXYANISOLE
BUTYLATED HYDROXYTOLUENE
CANDELILLA WAX
YELLOW WAX
CETOSTEARYL ALCOHOL
CETEARYL GLUCOSIDE
carnauba wax
titanium dioxide
FERRIC OXIDE YELLOW
ferric oxide red
FERROSOFERRIC OXIDE

Product Characteristics

Color
BROWN (Beige 4)

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:13537-320-01 30 in 1 JAR
2 NDC:13537-320-02 1 in 1 BOX

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2011-05-17


ESIKA

OCTINOXATE POWDER

Product Information

Product Type Human otc drug label Item Code (Source) NDC:13537-321
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 0.06 g

Inactive Ingredients

Ingredient Name Strength
water
ETHYLHEXYL PALMITATE
GLYCERIN
OCTYLDODECANOL
CYCLOMETHICONE 5
POLYGLYCERYL-4 ISOSTEARATE
SODIUM CHLORIDE
talc
DIMETHICONE
HEXYL LAURATE
cyclomethicone
CYCLOMETHICONE 6
SOYBEAN
MICROCRYSTALLINE WAX
DIAZOLIDINYL UREA
METHYLPARABEN
PROPYLPARABEN
petrolatum
TRIETHOXYCAPRYLYLSILANE
CHOLESTEROL
SILICON DIOXIDE
BUTYLATED HYDROXYANISOLE
BUTYLATED HYDROXYTOLUENE
CANDELILLA WAX
YELLOW WAX
CETOSTEARYL ALCOHOL
CETEARYL GLUCOSIDE
carnauba wax
titanium dioxide
FERRIC OXIDE YELLOW
ferric oxide red
FERROSOFERRIC OXIDE

Product Characteristics

Color
BROWN (Beige 5)

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:13537-321-01 30 in 1 JAR
2 NDC:13537-321-02 1 in 1 BOX

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2011-05-17


ESIKA

OCTINOXATE POWDER

Product Information

Product Type Human otc drug label Item Code (Source) NDC:13537-322
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 0.06 g

Inactive Ingredients

Ingredient Name Strength
water
ETHYLHEXYL PALMITATE
GLYCERIN
OCTYLDODECANOL
CYCLOMETHICONE 5
POLYGLYCERYL-4 ISOSTEARATE
SODIUM CHLORIDE
talc
DIMETHICONE
HEXYL LAURATE
cyclomethicone
CYCLOMETHICONE 6
SOYBEAN
MICROCRYSTALLINE WAX
DIAZOLIDINYL UREA
METHYLPARABEN
PROPYLPARABEN
petrolatum
TRIETHOXYCAPRYLYLSILANE
CHOLESTEROL
SILICON DIOXIDE
BUTYLATED HYDROXYANISOLE
BUTYLATED HYDROXYTOLUENE
CANDELILLA WAX
YELLOW WAX
CETOSTEARYL ALCOHOL
CETEARYL GLUCOSIDE
carnauba wax
titanium dioxide
FERRIC OXIDE YELLOW
ferric oxide red
FERROSOFERRIC OXIDE

Product Characteristics

Color
BROWN (Beige 6)

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:13537-322-01 30 in 1 JAR
2 NDC:13537-322-02 1 in 1 BOX

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2011-05-17


ESIKA

OCTINOXATE POWDER

Product Information

Product Type Human otc drug label Item Code (Source) NDC:13537-323
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 0.06 g

Inactive Ingredients

Ingredient Name Strength
water
ETHYLHEXYL PALMITATE
GLYCERIN
OCTYLDODECANOL
CYCLOMETHICONE 5
POLYGLYCERYL-4 ISOSTEARATE
SODIUM CHLORIDE
talc
DIMETHICONE
HEXYL LAURATE
cyclomethicone
CYCLOMETHICONE 6
SOYBEAN
MICROCRYSTALLINE WAX
DIAZOLIDINYL UREA
METHYLPARABEN
PROPYLPARABEN
petrolatum
TRIETHOXYCAPRYLYLSILANE
CHOLESTEROL
SILICON DIOXIDE
BUTYLATED HYDROXYANISOLE
BUTYLATED HYDROXYTOLUENE
CANDELILLA WAX
YELLOW WAX
CETOSTEARYL ALCOHOL
CETEARYL GLUCOSIDE
carnauba wax
titanium dioxide
FERRIC OXIDE YELLOW
ferric oxide red
FERROSOFERRIC OXIDE

Product Characteristics

Color
RED (Rosa 1)

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:13537-323-01 30 in 1 JAR
2 NDC:13537-323-02 1 in 1 BOX

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2011-05-17


ESIKA

OCTINOXATE POWDER

Product Information

Product Type Human otc drug label Item Code (Source) NDC:13537-324
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 0.06 g

Inactive Ingredients

Ingredient Name Strength
water
ETHYLHEXYL PALMITATE
GLYCERIN
OCTYLDODECANOL
CYCLOMETHICONE 5
POLYGLYCERYL-4 ISOSTEARATE
SODIUM CHLORIDE
talc
DIMETHICONE
HEXYL LAURATE
cyclomethicone
CYCLOMETHICONE 6
SOYBEAN
MICROCRYSTALLINE WAX
DIAZOLIDINYL UREA
METHYLPARABEN
PROPYLPARABEN
petrolatum
TRIETHOXYCAPRYLYLSILANE
CHOLESTEROL
SILICON DIOXIDE
BUTYLATED HYDROXYANISOLE
BUTYLATED HYDROXYTOLUENE
CANDELILLA WAX
YELLOW WAX
CETOSTEARYL ALCOHOL
CETEARYL GLUCOSIDE
carnauba wax
titanium dioxide
FERRIC OXIDE YELLOW
ferric oxide red
FERROSOFERRIC OXIDE

Product Characteristics

Color
RED (Rosa 2)

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:13537-324-01 30 in 1 JAR
2 NDC:13537-324-02 1 in 1 BOX

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2011-05-17


ESIKA

OCTINOXATE POWDER

Product Information

Product Type Human otc drug label Item Code (Source) NDC:13537-325
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 0.06 g

Inactive Ingredients

Ingredient Name Strength
water
ETHYLHEXYL PALMITATE
GLYCERIN
OCTYLDODECANOL
CYCLOMETHICONE 5
POLYGLYCERYL-4 ISOSTEARATE
SODIUM CHLORIDE
talc
DIMETHICONE
HEXYL LAURATE
cyclomethicone
CYCLOMETHICONE 6
SOYBEAN
MICROCRYSTALLINE WAX
DIAZOLIDINYL UREA
METHYLPARABEN
PROPYLPARABEN
petrolatum
TRIETHOXYCAPRYLYLSILANE
CHOLESTEROL
SILICON DIOXIDE
BUTYLATED HYDROXYANISOLE
BUTYLATED HYDROXYTOLUENE
CANDELILLA WAX
YELLOW WAX
CETOSTEARYL ALCOHOL
CETEARYL GLUCOSIDE
carnauba wax
titanium dioxide
FERRIC OXIDE YELLOW
ferric oxide red
FERROSOFERRIC OXIDE

Product Characteristics

Color
RED (Rosa 3)

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:13537-325-01 30 in 1 JAR
2 NDC:13537-325-02 1 in 1 BOX

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2011-05-17


ESIKA

OCTINOXATE POWDER

Product Information

Product Type Human otc drug label Item Code (Source) NDC:13537-326
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 0.06 g

Inactive Ingredients

Ingredient Name Strength
water
ETHYLHEXYL PALMITATE
GLYCERIN
OCTYLDODECANOL
CYCLOMETHICONE 5
POLYGLYCERYL-4 ISOSTEARATE
SODIUM CHLORIDE
talc
DIMETHICONE
HEXYL LAURATE
cyclomethicone
CYCLOMETHICONE 6
SOYBEAN
MICROCRYSTALLINE WAX
DIAZOLIDINYL UREA
METHYLPARABEN
PROPYLPARABEN
petrolatum
TRIETHOXYCAPRYLYLSILANE
CHOLESTEROL
SILICON DIOXIDE
BUTYLATED HYDROXYANISOLE
BUTYLATED HYDROXYTOLUENE
CANDELILLA WAX
YELLOW WAX
CETOSTEARYL ALCOHOL
CETEARYL GLUCOSIDE
carnauba wax
titanium dioxide
FERRIC OXIDE YELLOW
ferric oxide red
FERROSOFERRIC OXIDE

Product Characteristics

Color
RED (Rosa 4)

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:13537-326-01 30 in 1 JAR
2 NDC:13537-326-02 1 in 1 BOX

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2011-05-17


ESIKA

OCTINOXATE POWDER

Product Information

Product Type Human otc drug label Item Code (Source) NDC:13537-327
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 0.06 g

Inactive Ingredients

Ingredient Name Strength
water
ETHYLHEXYL PALMITATE
GLYCERIN
OCTYLDODECANOL
CYCLOMETHICONE 5
POLYGLYCERYL-4 ISOSTEARATE
SODIUM CHLORIDE
talc
DIMETHICONE
HEXYL LAURATE
cyclomethicone
CYCLOMETHICONE 6
SOYBEAN
MICROCRYSTALLINE WAX
DIAZOLIDINYL UREA
METHYLPARABEN
PROPYLPARABEN
petrolatum
TRIETHOXYCAPRYLYLSILANE
CHOLESTEROL
SILICON DIOXIDE
BUTYLATED HYDROXYANISOLE
BUTYLATED HYDROXYTOLUENE
CANDELILLA WAX
YELLOW WAX
CETOSTEARYL ALCOHOL
CETEARYL GLUCOSIDE
carnauba wax
titanium dioxide
FERRIC OXIDE YELLOW
ferric oxide red
FERROSOFERRIC OXIDE

Product Characteristics

Color
RED (Rosa 5)

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:13537-327-01 30 in 1 JAR
2 NDC:13537-327-02 1 in 1 BOX

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2011-05-17


ESIKA

OCTINOXATE POWDER

Product Information

Product Type Human otc drug label Item Code (Source) NDC:13537-328
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 0.06 g

Inactive Ingredients

Ingredient Name Strength
water
ETHYLHEXYL PALMITATE
GLYCERIN
OCTYLDODECANOL
CYCLOMETHICONE 5
POLYGLYCERYL-4 ISOSTEARATE
SODIUM CHLORIDE
talc
DIMETHICONE
HEXYL LAURATE
cyclomethicone
CYCLOMETHICONE 6
SOYBEAN
MICROCRYSTALLINE WAX
DIAZOLIDINYL UREA
METHYLPARABEN
PROPYLPARABEN
petrolatum
TRIETHOXYCAPRYLYLSILANE
CHOLESTEROL
SILICON DIOXIDE
BUTYLATED HYDROXYANISOLE
BUTYLATED HYDROXYTOLUENE
CANDELILLA WAX
YELLOW WAX
CETOSTEARYL ALCOHOL
CETEARYL GLUCOSIDE
carnauba wax
titanium dioxide
FERRIC OXIDE YELLOW
ferric oxide red
FERROSOFERRIC OXIDE

Product Characteristics

Color
RED (Rosa 6)

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:13537-328-01 30 in 1 JAR
2 NDC:13537-328-02 1 in 1 BOX

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2011-05-17


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.